Hyperkalemia induced by the calcium channel blocker, benidipine

Internal Medicine

Volumn 42, Issue 6, 2003, Pages 503-506

  Imamura, Takuroh ^a   Matsuura, Yunosuke ^a   Nagoshi, Toshiro ^a   Ishikawa, Tetsunori ^a   Date, Haruhiko ^a   Kita, Toshihiro ^a   Matsuyama, Akihiko ^a   Matsuo, Takeshi ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Benidipine; Calcium channel blocker; Hyperkalemia; Potassium; Side effect

Indexed keywords

AMLODIPINE; AZELASTINE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CILAZAPRIL; DELAPRIL; FUROSEMIDE; POTASSIUM ION; PRAZOSIN; PROBUCOL; PROCATEROL; RESCINNAMINE; RESERPINE; SPIRONOLACTONE; VERAPAMIL;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; COUGHING; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; INFORMED CONSENT; POTASSIUM BLOOD LEVEL; PRESCRIPTION;

EID: 0041670964     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.503     Document Type: Article

References (22)

1. Brenner BM. Fluid and electrolyte disturbances. in: Harrison's Principles of Internal Medicine. 14th ed. Fauci AS, Brauwalde, Isselbacher KJ, et al., Eds. McGraw-Hill, New York, 1998: 265-277.
2. Ponce SP, Jennings AE, Madias NE, Harrington JT. Drug-induced hyperkalemia. Medicine 64: 357-370, 1985.
3. Jackson EK. Renin and angiotensin. in: Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. Hardman JG, Limberd LE, Gilman AG, Eds. McGraw-Hill, New York, 2001: 809-841.
4. Jackson EK. Diuretics. in: Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. Hardman JG, Limberd LE, Gilman AG, Eds. McGraw-Hill, New York, 2001: 757-787.
5. Lee TH, Salomon DR, Rayment CM, Antman EM. Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil/propranolol therapy. Am J Med 80: 1203-1204, 1986.
6. Rubin AS, Zablocki AD. Hyperkalemia, verapamil, and dantrolene. Anesthesiology 66: 246-249, 1987.
7. Pritza DR, Bierman MH, Hammeke MD. Acute toxic effects of sustained-release verapamil in chronic renal failure. Arch Intern Med 151: 2081-2084, 1991.
8. Jolly SR, Keaton N, Movahed A, Rose GC, Reeves WC. Effect of hyperkalemia on experimental myocardial depression by verapamil. Am Heart J 121: 517-523, 1991.
9. Vázquez C, Huelmos A, Alegria E, Errasti P, Purroy A. Verapamil deleterious effects in chronic renal failure. Nephron 72: 461-464, 1996.
10. Hoyt RE. Hyperkalemia due to salt substitutes. JAMA 256: 1726, 1986.
11. Freed MI, Rastegar A, Bia MJ. Effects of calcium channel blockers on potassium homeostasis. Yale J Biol Med 64: 177-186, 1991.
12. Watanabe Y, Kamei F. Clinical evaluation and safety of benidipine hydrochloride in long-term administration on elderly essential hypertensives. Therap Res 18: 297-310, 1997 (in Japanese).
13. Matsubara T, Ichimiya M, Kaneshiro M, et al. Effect of long-term benidipine hydrochloride (Coniel) treatment on serum lipids in patients with essential hypertension. Therap Res 18: 3951-3962, 1997 (in Japanese).
14. Saruta T, Suzuki H, Kato R. A study of benidipine hydrochloride in hypertensive patients with renal impairment in long-term treatment. Therap Res 19: 361-378, 1998 (in Japanese).
15. Bauer JH, Sunderrajan S, Reams G. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition. Am J Cardiol 56: 62H-67H, 1985.
16. Flicker MR, Quigley MA, Galdwell EG. Diltiazem and hyperkalemia. JAMA 258: 1891-1892, 1987.
17. Rooke GA, Freund PR, Tomlin J. Calcium channel blockers do not enhance increases in plasma potassium after succinylcholine in humans. J Clin Anesth 6: 114-118, 1994.
18. Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of development and hemodynamic effects of acute hyperkalemia in halothane-anesthetized dogs: Effects of calcium therapy. Anesthesiology 60: 435-439, 1984.
19. + and angiotensin II increase T-type Ca channel current. Proc Natl Acad Sci USA 85: 2412-2416, 1988.
20. Johson EI, McDougall JG, Coghlan JP, Denton DA, Scoggins BA, Wright RD. Potassium stimulation of aldosterone secretion in vivo is reversed by nisoldipine, a calcium transport antagonist. Endocrinology 114: 1466-1468, 1984.
21. Fakunding JL, Catt KJ. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: Effects of lanthanum and verapamil. Endocrinology 107: 1345-1353, 1980.
22. Blanchouin-Emeric N, Zenatti M, Defaye G, Aupetit B. Verapamil directly inhibits aldosterone synthesis by adrenal mitochondria in vitro. J Steroid Biochem 30: 453-456, 1988.